XTX Topco’s Better Therapeutics, Inc. Common Stock BTTX Stock Holding History

XTX Topco’s Portfolio BTTX Stock Details BTTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-32,670	Closed	-$457	–	2650
2024 Q1	$457	Buy	32,670 +18,198	+126%	+$3.35K	﹤0.01%	1772
2023 Q4	$2.82K	Buy	+14,472	New	+$3.15K	﹤0.01%	1496

Other funds holding BTTX

Ancora Advisors Cleveland, Ohio $5.19B AUM 23.19% 1-Year Est. Return

XTX Topco's BTTX Position: Q2 2024 in Review

XTX Topco sold out of Better Therapeutics, Inc. Common Stock (BTTX) in Q2 2024, closing a stake of 32,670 shares — an estimated $457 sold.

XTX Topco first reported a position in BTTX in Q4 2023 and held it in 2 quarters. The position peaked at $2.82K in Q4 2023. 1 fund tracked by Wall St. Rank holds BTTX as of Q2 2024.

XTX Topco reported no remaining Better Therapeutics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
XTX Topco sold 32,670 Better Therapeutics, Inc. Common Stock shares in Q2 2024, an estimated $457.
XTX Topco first reported a position in Better Therapeutics, Inc. Common Stock in Q4 2023 and held it in 2 quarters.
XTX Topco's Better Therapeutics, Inc. Common Stock position peaked at $2.82K in Q4 2023.
1 fund tracked by Wall St. Rank held Better Therapeutics, Inc. Common Stock as of Q2 2024.

Based on XTX Topco's 13F filing for Q2 2024, filed 12 Aug 2024.